These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 3133261)

  • 1. Effect of aldose reductase inhibition on nerve conduction velocity and resistance to ischemic conduction block in experimental diabetes.
    Price DE; Airey CM; Alani SM; Wales JK
    Diabetes; 1988 Jul; 37(7):969-73. PubMed ID: 3133261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
    Mayer JH; Tomlinson DR
    Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats.
    Cameron NE; Cotter MA; Robertson S
    Q J Exp Physiol; 1989 Nov; 74(6):917-26. PubMed ID: 2512591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow component-a of axonal transport, nerve myo-inositol, and aldose reductase inhibition in streptozocin-diabetic rats.
    Tomlinson DR; Sidenius P; Larsen JR
    Diabetes; 1986 Apr; 35(4):398-402. PubMed ID: 2420664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
    Gillon KR; Hawthorne JN; Tomlinson DR
    Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on peripheral nerve and lens in long-term experimental diabetes: effects of the aldose reductase inhibitor statil.
    Willars GB; Townsend J; Tomlinson DR; Compton AM; Churchill RD
    Metabolism; 1988 May; 37(5):442-9. PubMed ID: 2452959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination of the aldose reductase inhibitor, statil, and the prostaglandin E1 analogue, OP1206.alpha CD, completely improves sciatic motor nerve conduction velocity in streptozocin-induced chronically diabetic rats.
    Yasuda H; Sonobe M; Hisanaga T; Kawabata T; Maeda K; Kikkawa R; Shigeta Y
    Metabolism; 1992 Jul; 41(7):778-82. PubMed ID: 1320179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of aldose reductase inhibitor ONO 2235 on reduced sympathetic nervous system activity and peripheral nerve disorders in STZ-induced diabetic rats.
    Yoshida T; Nishioka H; Yoshioka K; Nakano K; Kondo M; Terashima H
    Diabetes; 1987 Jan; 36(1):6-13. PubMed ID: 3025043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced anterograde and retrograde accumulation of axonally transported phosphofructokinase in streptozotocin-diabetic rats: effects of insulin and the aldose reductase inhibitor 'Statil'.
    Willars GB; Calcutt NA; Tomlinson DR
    Diabetologia; 1987 Apr; 30(4):239-43. PubMed ID: 2439402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fast anterograde axonal transport in wasted and non-wasted diabetic rats; effects of aldose reductase inhibition.
    Whiteley SJ; Townsend J; Tomlinson DR; Willars GB
    Diabetes Res; 1986 Nov; 3(9):447-52. PubMed ID: 2435444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slow orthograde axonal transport of radiolabelled protein in sciatic motoneurones of rats with short-term experimental diabetes: effects of treatment with an aldose reductase inhibitor or myo-inositol.
    Mayer JH; Tomlinson DR; McLean WG
    J Neurochem; 1984 Nov; 43(5):1265-70. PubMed ID: 6208327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with an aldose reductase inhibitor can reduce the susceptibility of fast axonal transport following nerve compression in the streptozotocin-diabetic rat.
    Dahlin LB; Archer DR; McLean WG
    Diabetologia; 1987 Jun; 30(6):414-8. PubMed ID: 2445613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Ultrastructural and morphometric studies of sural nerve in streptozocin-induced diabetic rats.
    Yagihashi S; Kamijo M; Ido Y; Mirrlees DJ
    Diabetes; 1990 Jun; 39(6):690-6. PubMed ID: 2140802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
    Tomlinson DR; Moriarty RJ; Mayer JH
    Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose-response considerations and independence from a myo-inositol mechanism.
    Cameron NE; Cotter MA; Dines KC; Maxfield EK; Carey F; Mirrlees DJ
    Diabetologia; 1994 Jul; 37(7):651-63. PubMed ID: 7958535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased resistance to hypoxic conduction block in sciatic nerves of diabetic rats: effects of extracellular glucose concentration and of aldose reductase inhibition.
    Carrington AL; Ettlinger CB; Tomlinson DR
    J Diabetes Complications; 1994; 8(1):33-9. PubMed ID: 8167385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
    Whiting PH; Ross IS
    Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a new aldose reductase inhibitor, 8'-chloro-2',3'-dihydrospiro [pyrrolidine-3,6'(5'H)-pyrrolo[1,2,3-de] [1,4]benzoxazine]-2,5,5'- trione (ADN-138), on delayed motor nerve conduction velocity in streptozotocin-diabetic rats.
    Hirata Y; Fujimori S; Okada K
    Metabolism; 1988 Feb; 37(2):159-63. PubMed ID: 2828821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats.
    Kikkawa R; Hatanaka I; Yasuda H; Kobayashi N; Shigeta Y; Terashima H; Morimura T; Tsuboshima M
    Diabetologia; 1983 Apr; 24(4):290-2. PubMed ID: 6407887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductase inhibitor 'statil'.
    Robinson JP; Willars GB; Tomlinson DR; Keen P
    Brain Res; 1987 Nov; 426(2):339-48. PubMed ID: 2446712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.